https://www.creon.co.uk/2020-03-25T14:48:01+00:001.00https://www.creon.co.uk/en-gb2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/hcp2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/en-gb/why-me2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/en-gb/how-creon-works2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/en-gb/how-to-take-creon2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/en-gb/what-to-watch-out-for2020-03-25T14:48:01+00:000.80https://www.creon.co.uk/-/media/CreonCoUk/assets/pdf/Creon_PI_May_2015.pdf2017-10-04T16:18:41+00:000.80https://www.creon.co.uk/en-gb/hcp2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/Home2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/most-common-causes-of-pei2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/mode-of-action2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing/introduction-to-effective-dosing2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing/dosing-flexibility2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing/dosing-and-administration-in-adults2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing/dosing-and-administration-in-children2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/effective-dosing/writing-a-creon-prescription2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability/introduction-to-efficacy-and-tolerability2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability/chronic-pancreatitis2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability/pancreatic-cancer2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability/cystic-fibrosis2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/efficacy-and-tolerability/other-conditions2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/resources2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/resources/resources2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/en-gb/hcp/resources/diabetes-survey2020-03-25T14:48:01+00:000.64https://www.creon.co.uk/-/media/creoncouk/assets/pdf/uk_pi_creon_021_final.pdf?la=en-gb2019-08-16T07:48:05+00:000.64https://www.creon.co.uk/-/media/creoncouk/assets/pdf/00658_17-creon-pert-booklet-revised-aw-2-hr-final.pdf?la=en-gb2019-09-10T12:06:53+00:000.64https://www.creon.co.uk/-/media/creoncouk/assets/pdf/creon_pi_aebox.pdf?la=en-gb2019-09-09T10:13:09+00:000.64https://www.creon.co.uk/-/media/creoncouk/assets/pdf/creon-dosingcard.pdf?la=en-gb2019-08-16T10:10:24+00:000.51https://www.creon.co.uk/-/media/creoncouk/assets/pdf/100536-aw03-cre-patient-tear_off-pad-a5_v3.pdf?la=en-gb2019-09-17T07:46:57+00:000.51